FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

12 results

abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for the treatment of various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and certain pediatric patients.
abrilada
(adalimumab-afzb)
Pfizer Laboratories Div Pfizer Inc
Usage: ABRILADA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients.
adalimumab
(adalimumab-fkjp)
Biocon Biologics Inc
Usage: Adalimumab-fkjp is indicated for treating moderate to severe rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients (ages vary by condition).
adalimumab-ryvk
(adalimumab-ryvk)
Quallent Pharmaceuticals Health LLC
Usage: Adalimumab-ryvk is indicated for various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, aiming to reduce symptoms and inhibit disease progression.
amjevita
(adalimumab-atto)
Optum Health Solutions (Ireland) Limited
Usage: AMJEVITA is indicated for various conditions including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis, either alone or in combination with other therapies.
amjevita
(adalimumab-atto)
Amgen Inc
Usage: AMJEVITA is indicated for treating various conditions, including rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, depending on the specific condition.
bimzelx
(bimekizumab)
UCB, Inc.
Usage: BIMZELX is used to treat moderate to severe plaque psoriasis, active psoriatic arthritis, active non-radiographic axial spondyloarthritis with inflammation, active ankylosing spondylitis, and moderate to severe hidradenitis suppurativa in adults who qualify for systemic therapy or phototherapy.
cosentyx
(secukinumab)
Novartis Pharmaceuticals Corporation
Usage: COSENTYX is indicated for treating moderate to severe plaque psoriasis in patients 6 years and older, active psoriatic arthritis from age 2, adult ankylosing spondylitis, active non-radiographic axial spondyloarthritis, active enthesitis-related arthritis in patients 4 years and older, and moderate to severe hidradenitis suppurativa in adults.
cyltezo
(adalimumab-adbm)
Boehringer Ingelheim Pharmaceuticals, Inc.
Usage: CYLTEZO is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients aged 2 and older.
hadlima
(adalimumab-bwwd)
Organon LLC
Usage: HADLIMA is indicated for treating moderately to severely active rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and pediatric patients, either alone or in combination with other therapies.

Medications for Hidradenitis Suppurativa

abrilada

abrilada

adalimumab

adalimumab-ryvk

amjevita

amjevita

bimzelx

cosentyx

cyltezo

hadlima